These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 37220183

  • 1. Neuropilin-1 interacts with VE-cadherin and TGFBR2 to stabilize adherens junctions and prevent activation of endothelium under flow.
    Bosseboeuf E, Chikh A, Chaker AB, Mitchell TP, Vignaraja D, Rajendrakumar R, Khambata RS, Nightingale TD, Mason JC, Randi AM, Ahluwalia A, Raimondi C.
    Sci Signal; 2023 May 23; 16(786):eabo4863. PubMed ID: 37220183
    [Abstract] [Full Text] [Related]

  • 2. Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability.
    Gioelli N, Neilson LJ, Wei N, Villari G, Chen W, Kuhle B, Ehling M, Maione F, Willox S, Brundu S, Avanzato D, Koulouras G, Mazzone M, Giraudo E, Yang XL, Valdembri D, Zanivan S, Serini G.
    Nat Commun; 2022 Jul 20; 13(1):4188. PubMed ID: 35858913
    [Abstract] [Full Text] [Related]

  • 3. Distribution of adherens junction mediated by VE-cadherin complex in rat spleen sinus endothelial cells.
    Uehara K.
    Cell Tissue Res; 2006 Mar 20; 323(3):417-24. PubMed ID: 16244888
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. VE-cadherin is a critical endothelial regulator of TGF-beta signalling.
    Rudini N, Felici A, Giampietro C, Lampugnani M, Corada M, Swirsding K, Garrè M, Liebner S, Letarte M, ten Dijke P, Dejana E.
    EMBO J; 2008 Apr 09; 27(7):993-1004. PubMed ID: 18337748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. IQ domain GTPase-activating protein 1 is involved in shear stress-induced progenitor-derived endothelial cell alignment.
    Rami L, Auguste P, Thebaud NB, Bareille R, Daculsi R, Ripoche J, Bordenave L.
    PLoS One; 2013 Apr 09; 8(11):e79919. PubMed ID: 24278215
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, Harting M, Redell JB, Grill R, Matsuo Y, Guha S, Cox CS, Reitz MS, Holcomb JB, Dash PK.
    Stem Cells Dev; 2011 Jan 09; 20(1):89-101. PubMed ID: 20446815
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling.
    Cook BD, Ferrari G, Pintucci G, Mignatti P.
    J Cell Biochem; 2008 Dec 15; 105(6):1367-73. PubMed ID: 18980215
    [Abstract] [Full Text] [Related]

  • 13. Knockdown of P120 catenin aggravates endothelial injury under an impinging flow by inducing breakdown of adherens junctions.
    Zhao JL, Xiao ZP, Yu NZ, Jiang JW, Li MH.
    Mol Med Rep; 2019 Jan 15; 19(1):541-548. PubMed ID: 30431117
    [Abstract] [Full Text] [Related]

  • 14. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
    Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, Malik AB.
    Circ Res; 2012 Aug 31; 111(6):739-49. PubMed ID: 22798526
    [Abstract] [Full Text] [Related]

  • 15. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
    Hatanaka K, Lanahan AA, Murakami M, Simons M.
    PLoS One; 2012 Aug 31; 7(5):e37600. PubMed ID: 22629427
    [Abstract] [Full Text] [Related]

  • 16. Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions.
    Friedrich EE, Hong Z, Xiong S, Zhong M, Di A, Rehman J, Komarova YA, Malik AB.
    Proc Natl Acad Sci U S A; 2019 Jun 25; 116(26):12980-12985. PubMed ID: 31186359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.